Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
This constitutes a medical emergency requiring immediate evaluation in an emergency department
For intervention and comparison: SGLT-2 Inhibitor OR SGLT-2 Inhibitors OR Sodium-Glucose Transporter 2 Inhibitors OR canagliflozin OR empagliflozin OR dapagliflozin OR ipragliflozin OR luseogliflozin OR tofogliflozin OR remogliflozin OR sergliflozin OR sotagliflozin OR ertugliflozin OR GLP-1 receptor agonist OR GLP-1 receptor agonists OR glucagon like peptide 1 receptor agonist OR GLP-1 agonists OR exenatide OR liraglutide OR albiglutide OR lixisenatide OR semaglutide OR dulaglutide OR taspoglutide
GRD1 Background Gene Name: GSR UniProt Entry: P00390 NCBI Gene Entry: 2936 Application Information Molecular Weight: Predicted, 56 kDa
If these trials continue to show positive results, Retatrutide could become available for clinical use within the next several years
Enhanced Stability Design D-retro-inverso peptide configuration improves resistance to enzymatic breakdown during laboratory studies
US$ 23.02
US$ 28.23
US$ 23.23
US$ 20.87
US$ 25.37
US$ 29.75
US$ 27.37
US$ 22.32
US$ 29.62
US$ 25.86
